EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC 4.0

Long‐term efficacy of autologous cell therapy, repeated PTA and conservative treatment in people with diabetes and chronic limb‐threatening ischaemia

M Dubský, D Sojáková, J Husáková, A Němcová, V Fejfarová, R Jarošíková, V Frelichová, K Sutoris, E B Jude iD

Diabetes, Obesity and Metabolism · 2025-09 · 27 (9) · 4729-4736

DOI: 10.1111/dom.16510 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 09.06.2025. Verfasst von M Dubský und 8 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. Hauptthemen laut MEDLINE: Diabetic Foot, Conservative Treatment, Ischemia, Angioplasty. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: European Union - Next Generation EU.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims Data about long‐term clinical outcomes of revascularization procedures, especially for autologous cell therapy (ACT), in diabetic patients with chronic limb‐threatening ischaemia (CLTI) are lacking. The aim of our study was to compare the mortality and amputation rates in patients with diabetic foot ulcers (DFU) and CLTI treated by ACT with patients treated by repeated percutaneous transluminal angioplasty (re‐PTA) and those treated conservatively. Materials and Methods One‐hundred and thirty patients with DFU and CLTI (defined as transcutaneous oxygen pressure—TcPO 2

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic FootConservative TreatmentIschemiaAngioplastyChronic Limb-Threatening IschemiaCell- and Tissue-Based TherapyHumansMaleFemaleMiddle AgedAgedAmputation, SurgicalTreatment OutcomeTransplantation, AutologousLimb Salvage

Stichwörter der Autor:innen

cellular researchclinical trialdiabetes complicationseffectiveness

Autor:innen und Institutionen

  • Diabetes Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
  • First Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Second Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Diabetes Center, Tameside and Glossop Integrated Care NHS Foundation Trust, Ashton under Lyne and University of Manchester, Manchester, UK.

ORCID-Profile: E B Jude

Förderung

  • European Union - Next Generation EU

Zitieren

APA

Dubský, M., Sojáková, D., Husáková, J., Němcová, A., Fejfarová, V., Jarošíková, R., Frelichová, V., Sutoris, K., & Jude, E. B. (2025). Long‐term efficacy of autologous cell therapy, repeated PTA and conservative treatment in people with diabetes and chronic limb‐threatening ischaemia. Diabetes, Obesity and Metabolism, 27(9), 4729-4736. https://doi.org/10.1111/dom.16510

Vancouver

Dubský M, Sojáková D, Husáková J, Němcová A, Fejfarová V, Jarošíková R, et al. Long‐term efficacy of autologous cell therapy, repeated PTA and conservative treatment in people with diabetes and chronic limb‐threatening ischaemia. Diabetes, Obesity and Metabolism. 2025;27(9):4729-4736. doi:10.1111/dom.16510

BibTeX
@article{Dubsk2025,
  author = {Dubský, M and Sojáková, D and Husáková, J and Němcová, A and Fejfarová, V and Jarošíková, R and Frelichová, V and Sutoris, K and Jude, E B},
  title = {Long‐term efficacy of autologous cell therapy, repeated PTA and conservative treatment in people with diabetes and chronic limb‐threatening ischaemia},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2025},
  volume = {27},
  number = {9},
  pages = {4729--4736},
  doi = {10.1111/dom.16510}
}
Kostenlos starten →